IndraLab

Statements


RARA activates USP37. 1 / 1
| 1

reach
"The retinoic acid receptor alpha (RARA) and the promyelocytic leukemia zinc finger (PLZF) fusion protein is a target of USP37 and the stabilization of PLZF and oncogenic transformation of acute promyelocytic leukemia cells has been attributed to USP37."